Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Evaluation of FDG PET in Patients with Cervical Cancer

Yoshifumi Sugawara, Avraham Eisbruch, Shigeru Kosuda, Betty E. Recker, Paul V. Kison and Richard L. Wahl
Journal of Nuclear Medicine July 1999, 40 (7) 1125-1131;
Yoshifumi Sugawara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avraham Eisbruch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeru Kosuda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Betty E. Recker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul V. Kison
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Wahl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 40, Issue 7
July 1, 1999
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of FDG PET in Patients with Cervical Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of FDG PET in Patients with Cervical Cancer
Yoshifumi Sugawara, Avraham Eisbruch, Shigeru Kosuda, Betty E. Recker, Paul V. Kison, Richard L. Wahl
Journal of Nuclear Medicine Jul 1999, 40 (7) 1125-1131;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of FDG PET in Patients with Cervical Cancer
Yoshifumi Sugawara, Avraham Eisbruch, Shigeru Kosuda, Betty E. Recker, Paul V. Kison, Richard L. Wahl
Journal of Nuclear Medicine Jul 1999, 40 (7) 1125-1131;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Lymph Node Assessment with 18F-FDG-PET and MRI in Uterine Cervical Cancer
  • Impact of 18F-FDG PET/CT with Retrograde Filling of the Urinary Bladder in Patients with Suspected Pelvic Malignancies
  • Lymph Node Staging by Positron Emission Tomography in Cervical Cancer: Relationship to Prognosis
  • PET in Cervical Cancer -- Implications for `Staging,' Treatment Planning, Assessment of Prognosis, and Prediction of Response
  • 18F-FDG PET/CT Delayed Images After Diuretic for Restaging Invasive Bladder Cancer
  • PET-Based Treatment Planning in Radiotherapy: A New Standard?
  • Low Value of [18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Primary Staging of Early-Stage Cervical Cancer Before Radical Hysterectomy
  • 18F-FDG PET Imaging in Posttherapy Monitoring of Cervical Cancers: From Diagnosis to Prognosis
  • Prospective Feasibility Trial of Radiotherapy Target Definition for Head and Neck Cancer Using 3-Dimensional PET and CT Imaging
  • Why Nearly All PET of Abdominal and Pelvic Cancers Will Be Performed as PET/CT
  • Delayed 18F-FDG PET for Detection of Paraaortic Lymph Node Metastases in Cervical Cancer Patients
  • Value of Dual-Phase 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Cervical Cancer
  • Imaging of Gynecologic Tumors: Comparison of 11C-Choline PET with 18F-FDG PET
  • Evaluation of 18F-FDG PET in Patients with Advanced, Metastatic, or Recurrent Gastric Cancer
  • Evaluation of 18F-FDG PET with Bladder Irrigation in Patients with Uterine and Ovarian Tumors
  • Detection of Early Recurrence with 18F-FDG PET in Patients with Cervical Cancer
  • Improved Prognostic Value of 18F-FDG PET Using a Simple Visual Analysis of Tumor Characteristics in Patients with Cervical Cancer
  • Lymph Node Staging by Positron Emission Tomography in Patients With Carcinoma of the Cervix
  • A Tabulated Summary of the FDG PET Literature
  • Google Scholar

More in this TOC Section

  • Eligibility for 177Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
  • Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2—Technical)
  • Fetal Dose from PET and CT in Pregnant Patients
Show more Clinical Investigation

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire